Related Experiment Videos
Neuroleptic malignant syndrome in striatonigral degeneration
1Division of Child Neurology, Tottori University Faculty of Medicine, Yonago, Japan.
Pediatric Neurology
|October 1, 1995
Summary
Neuroleptic malignant syndrome, a rare condition, can occur in children with striatonigral degeneration following respiratory infections. Prompt dantrolene treatment proved effective in this case.
Area of Science:
- Neurology
- Pediatrics
Background:
- Striatonigral degeneration is a rare neurological disorder affecting the basal ganglia.
- Neuroleptic malignant syndrome (NMS) is a life-threatening condition typically associated with antipsychotic medications.
Observation:
- A 6-year-old boy with diagnosed striatonigral degeneration experienced an episode of NMS.
- The NMS episode was triggered by an upper respiratory infection, a previously unreported cause.
Findings:
- The patient's NMS resolved successfully with dantrolene treatment.
- This case highlights a novel association between respiratory infections and NMS in pediatric basal ganglia disorders.
Implications:
- Patients with striatonigral degeneration may be at increased risk for NMS, even from non-pharmacological triggers like infections.
- Early recognition and treatment of NMS are crucial in pediatric patients with basal ganglia disorders to prevent severe morbidity.